No Data
Positive Earnings Growth Hasn't Been Enough to Get C-MER Medical Holdings (HKG:3309) Shareholders a Favorable Return Over the Last Three Years
C-MER MEDICAL: 2024 INTERIM REPORT
C-MER Medical Chairman Bolsters Shareholding
Express News | C-Mer Medical Holdings - on Sept 12, Chairman Purchased 1.2 Mln Shares of Co for HK$2.4 Mln
Hima Medical (03309.HK) received an increase in shareholding of 1.004 million shares from Chairman, CEO and Executive Director Lin Shunchao.
According to the latest equity disclosure information from the Hong Kong Stock Exchange, from September 12th to September 16th, 2024, Xima Medical (03309.HK) chairman, CEO and executive director Lin Shunchao purchased a total of 1.004 million shares at an average price of HK$2.0308-2.0571 per share, with a total investment of approximately HK$2.05 million. After the shareholding, Lin Shunchao's latest shareholding is 691,616,553 shares, and the shareholding ratio has increased from 55.00% to 55.08%.
Shares of Xima Medical (03309) fell 39.00%, now trading at HKD 1.820, hitting a 52-week low.
As of 11:46, Xima Medical (03309) has dropped 39.00% compared to the previous closing price, currently at 1.820 yuan, hitting a new 52-week low; the volume of trade is 0.538 million shares, with a turnover of 0.9845 million Hong Kong dollars.
C-MER Eye Care Holdings (HKG:3309 Investor Three-year Losses Grow to 49% as the Stock Sheds HK$449m This Past WeekNo Data
No Data
